Zacks Investment Research on MSN
WST launches Synchrony S1 prefillable syringe at Pharmapack
West Pharmaceutical Services WST recently announced the global commercial availability of the West Synchrony S1 prefillable ...
BFS is particularly suited for products that benefit from speed, unit dose convenience, and reduced breakage risk. Plastic ...
In October 2025, Sharp announced plans to invest $100 million across its United States and European facilities to expand ...
Several recent steps move the closure toward commercializationNew studies confirm the system’s usability and ...
(RTTNews) - Celltrion Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO (omalizumab-igec)—the first and only biosimilar designated as ...
The addition of a new 300mg presentation allows for greater dosing flexibility to ease overall treatment burden and discomfort. The interchangeable biosimilar was originally approved in March 2025 in ...
INCHEON, Korea--(BUSINESS WIRE)--#amd--Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive ...
KYIV, Ukraine (AP) — The soil surrounding the gas facility in Ukraine was once pitch-black before it was burned to a rusty red by a massive Russian drone and missile assault. Scattered remnants of ...
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area with seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results